cancer screening

News

Two senior executives formerly at BioNTech have launched a new biotech, Bios Life, that they call "an AI-native cancer surveillance company."

Oncology

Liquid biopsy-based tools are positioned as a critical enabler of tumour-agnostic therapeutic development.

Oncology

Dr Philip Kantoff, a world-renowned prostate cancer clinician and researcher, discusses alpha radiopharma treatment possibilities.

News

The UK's National Screening Committee has concluded that the harms of widespread prostate cancer screening would outweigh its benefits.

R&D

Behavioural phenomena are particularly consequential in screening and prevention research in oncology.

News

A machine learning algorithm could serve as a pre-screen for hepatocellular carcinoma that identifies patients missed by current narrow guidance.